Skip to main content
. Author manuscript; available in PMC: 2023 Jan 28.
Published in final edited form as: J Control Release. 2022 Sep 7;350:668–687. doi: 10.1016/j.jconrel.2022.08.051

Fig. 6.

Fig. 6.

Types of brain-targeted nanomedicine and BBB-targeting peptides derived from venom. A) Commonly reported nanomedicines for brain delivery. B and C) Peptides designed for BBB penetration.